Skip to main content
. 2020 Aug 1;10(8):131. doi: 10.3390/life10080131

Table 1.

Representative therapy strategies for targeting lncRNAs.

Strategy Chemistry Mechanism of Action Refs
Down-regulation ASO gapmers An ASO consists of a central DNA region flanked by modified nucleotides; the DNA-RNA hybrid recruits ribonuclease H and promotes degradation of target mRNA [12]
siRNA siRNA gets incorporated into other proteins to form the RISC; siRNA is unwound and find a complementary mRNA and RISC induces mRNA cleavage [66]
shRNA Ribonuclease protein Dicer binds and cleaves shRNA into siRNA; siRNA gets incorporated into other proteins to form the RISC; siRNA is unwound and find a complementary mRNA and RISC induces mRNA cleavage [66]
Up-regulation Adeno-associated virus Insert the full length of lncRNAs into vectors; target cells uptake these vectors and up-regulates lncRNA expression [8,62,156]

ASO, antisense oligonucleotide; siRNA, small interfering RNA; shRNA, short hairpin RNA; RISC, RNA-induced silencing complex.